Merck Manual

Please confirm that you are a health care professional

Loading

Monocytopenia

By

Mary Territo

, MD, David Geffen School of Medicine at UCLA

Last full review/revision Jan 2020| Content last modified Jan 2020
Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version

Monocytopenia is a reduction in blood monocyte count to < 500/mcL (< 0.5 × 109/L). Risk of certain infections is increased. It is diagnosed by complete blood count with differential. Treatment with hematopoietic stem cell transplantation may be needed.

Monocytes migrate into the tissues where they become macrophages, with specific characteristics depending on their tissue localization.

Monocytopenia can increase the risk of infection, and it can indicate poor prognosis in patients with acetaminophen-induced hepatic damage and thermal injuries. Peripheral blood monocytopenia does not usually indicate a decrease in tissue macrophages; in some cases it can be associated with impaired granuloma formation in response to infections.

Monocytopenia can result from

Transient monocytopenia can occur with endotoxemia, hemodialysis, or cyclic neutropenia.

Monocytopenia due to GATA2 mutation

A severe deficiency or absence of monocytes can occur in patients with mutations of the hematopoietic transcription factor gene, GATA2. Dendritic cells are decreased, and there may also be lymphocytopenia (mainly natural killer and B cells).

Despite near-absence of circulating monocytes, tissue macrophages are usually preserved. Also, immunoglobulin levels are usually normal even when circulating B cells are depressed. Bone marrow is hypocellular and can show fibrosis and multilineage dysplasia. Karyotypic abnormalities, including monosomy 7 and trisomy 8, may be present.

Infections with Mycobacterium avium complex (MAC) or other nontuberculous mycobacterial infections are common (MonoMAC syndrome). Fungal infections (ie, histoplasmosis, aspergillosis) also are typical. Infections with human papillomavirus (HPV) may occur with subsequent risk of progression to secondary cancers. There is a high risk of progression to hematologic disorders (myelodysplasia, acute myeloid leukemia, chronic myelomonocytic leukemia, lymphomas) with a resulting poor prognosis.

Unvaccinated patients should be given HPV vaccination. Any infections are treated with appropriate antimicrobials. Allogeneic hematopoietic stem cell transplantation should be considered for symptomatic patients.

Drugs Mentioned In This Article

Drug Name Select Trade
TYLENOL
Click here for Patient Education
NOTE: This is the Professional Version. CONSUMERS: Click here for the Consumer Version
Professionals also read

Also of Interest

Videos

View All
Overview of Hemochromatosis
Video
Overview of Hemochromatosis
Overview of Acute Leukemia
Video
Overview of Acute Leukemia

SOCIAL MEDIA

TOP